Page 1 of 9
DAK Americas LLC
Material Safety Data She et
MSDS NUMBER: DK0001
REVISION DATE: 01/21/2008
---------------------------------------------------------------------------
TEREPHTHALIC ACID (ALL GRADES)
--------------------------------------------------------------------------
--------------------------------------------------------------------------
CHEMICAL PRODUCT/COMPANY IDENTIFICATION
--------------------------------------------------------------------------
MATERIAL IDENTIFICATION:
Formula: HOOCC6H4COOH
Molecular Weight: 166.13
CAS Name: 1,4-BENZENEDICARBOXYLIC ACID
# Tradenames a nd Syno nyms:
1,4-BENZENEDICARBOXYLIC ACID
KP-12
T PA
PGTPA
P TA
C OMPANY IDENTIFICATION:
MANUFACTURER/DISTRIBUTOR:
DAK Americas LLC
3500 Daniels Road NE
Leland, NC 28451
PHONE NUMBERS:
FOR INFORMATION CALL: 1-877-432-2766
TRANSPORT EMERGENCY CALL: 1-800-424-9300
---------------------------------------------------------------------------
C OMP OSITION/INFORMATION ON INGREDIENTS
---------------------------------------------------------------------------
C OMP ONENTS:
Material CAS Number %
TEREPHTHALIC ACID 100-21-0 >99.8
ACETIC ACID 64-19-7 0.15
Page 2 of 9
DAK Americas LLC
Material Safety Data She et
---------------------------------------------------------------------------
HAZARDS IDENTIFICATION
---------------------------------------------------------------------------
POTENTIAL HEALTH EFFECTS:
This compound is a slight eye irritant. High or prolonged oral exposure may result in kidney changes,
blood in the urine or bladder stones.
Terephthalic acid caused cancer in rats at large oral doses.
Eye contact may cause slight irritation, with discomfort, tearing, or blurring of vision. Inhalation may
cause irritation of mucosal surfaces. Based on animal studies, high or prolonged oral exposure may result
in kidney changes, blood in the urine or bladder stones.
CARCINOGENICITY INFORMATION:
None of the components present in this material at concentrations equal to or greater than 0.1% are
listed by IARC, NTP, OSHA or ACGIH as a carcinogen.
---------------------------------------------------------------------------
FIRST AID MEASURES
---------------------------------------------------------------------------
FIRST AID:
INHALATION:
If large amounts are inhaled, remove to fresh air. If not breathing, give artificial respiration. If
breathing is difficult, give oxygen. Call a physician.
SKIN C ONTACT:
Flush skin with water after excessive contact. Wash contaminated clothing before reuse.
EYE CONTACT:
In case of contact, immediately flush eyes with plenty of water for at least 15 minutes. Call a
physician.
INGESTION:
If swallowed, immediately give 2 glasses of water and induce vomiting. Never give anything by mouth
to an unconscious person. Call a physician.
Page 3 of 9
DAK Americas LLC
Material Safety Data She et
--------------------------------------------------------------------------
FIRE FIGHTING MEASURES
--------------------------------------------------------------------------
FLAMMABLE PROPERTIES:
Flash Point: 260 C (500 F)
Method: OC
Auto-ignition: 677 C (1251 F)
Dust forms explosive mixture with air.
Hazardous gases/vapors produced in fire are carbon monoxide
FIRE AND EXPLOSION HAZARDS:
High-voltage static electricity buildup is possible when significant quantities of dust are present in the
air. This can be a potential source of ignition.
EXTINGUISHING MEDIA:
Water, Water Spray, Foam, Dry Chemical.
Carbon Dioxide (CO2).
FIRE FIGHTING INSTRUCTIONS:
Wear self-contained breathing apparatus. Wear full protective equipment.
Keep personnel removed and upwind of fire.
---------------------------------------------------------------------------
ACCIDENTAL RELEASE MEASURES
---------------------------------------------------------------------------
SAFEGUARDS (PERSONNEL):
NOTE: Review FIRE FIGHTING MEASURES and HANDLING (PERSONNEL) sections before
proceeding with clean-up. Use appropriate PERSONAL PROTECTIVE EQUIPMENT during clean-up.
INITIAL CONTAINMENT:
Remove source of heat, sparks, flame, impact, friction or electricity.
SPILL CLEAN UP:
Recover undamaged and minimally contaminated material for reuse and reclamation.
Page 4 of 9
DAK Americas LLC
Material Safety Data She et
---------------------------------------------------------------------------
HANDLING AND STORAGE
---------------------------------------------------------------------------
HANDLING (PERSONNEL):
Avoid breathing dust. Avoid contact with eyes, skin, or clothing.
Wash thoroughly after handling.
HANDLING (PHYSICAL ASPECTS):
Avoid dust generation. Close container after each use. Keep away from heat, sparks and flames.
STORAGE:
Do not mix with strong oxidants. Store in a well-ventilated place. Keep container tightly closed.
---------------------------------------------------------------------------
EXPOSURE CONTROLS/PERSONAL PROTECTION
---------------------------------------------------------------------------
ENGINEERING C ONTROLS:
Keep container tightly closed.
Use sufficient ventilation to keep employee exposure below recommended exposure limits.
# PERSONAL PROTECTIVE EQUIPMENT:
EYE/FACE PROTECTION:
Wear safety glasses. Wear coverall chemical splash goggles and face shield when the possibility exists
for eye or face contact from airborne material.
RESPIRATORS:
A NIOSH approved air purifying respirator with a dust cartridge or canister may be permissible under
certain circumstances where airborne concentrations are expected to exceed exposure limits. Protection
provided by air purifying respirators is limited. Use a positive pressure air supplied respirator if there is
any potential for an uncontrolled release, exposure levels are not known, or any other circumstances
where air purifying respirators may not provide adequate protection.
PROTECTIVE CLOTHING:
Wear impervious clothing, such as gloves, apron, boots, or whole bodysuit made from butyl rubber, as
appropriate.
DAK Americas LLC
Material Safety Data She et
---------------------------------------------------------------------------
Page 5 of 9
EXPOSURE CONTROLS/PERSONAL PROTECTION
---------------------------------------------------------------------------
EXPOSURE GUIDELINES:
Applicable Exposure Limits
TEREPHTHALIC ACID:
PEL (OSHA): None Established
TLV (ACGIH): 10 mg/m3, 8 Hr. TWA
AEL * (DUPONT): 10 mg/m3, total dust, 5 mg/m3, respirable dust 8 Hr. T WA
WEEL (AIHA): None Established
ACETIC ACID:
PEL (OSHA): 10 ppm, 25 mg/m3, 8 Hr. TWA
TLV (ACGIH): 10 ppm, 25 mg/m3, 8 Hr. TWA
STEL 15 ppm, 37 mg/m3
AEL * (DUPONT): 10 ppm, 8 & 12 Hr. TWA
AEL is DUPONT"S Acceptable Exposure Limit. Where governmentally imposed occupational
exposure limits which are lower than the AEL are in effect, such limits shall take precedence.
鈥? DAK AMERICAS ACCEP TS DUPONT'S AEL.
---------------------------------------------------------------------------
PHYSICAL AND CHEMICAL PROPERTIES
---------------------------------------------------------------------------
PHYSICAL DATA:
Boiling Point: Sublimes above 300 deg C (570 deg F)
Vapor Pressure: <0.01 mm Hg @ 20 C (68 F)
Melting Point: >300 C (>572 F)
Solubility in Water: Negligible
Odor: Vinegar
Form: Powder
Color: White
Specific Gravity: 1.51
PHYSICAL HAZARDS:
Vapor space above TPA may contain acetic acid in concentrations above its exposure limits.
DAK Americas LLC
Material Safety Data She et
---------------------------------------------------------------------------
STABILITY AND REACTIVITY
---------------------------------------------------------------------------
Page 6 of 9
CHEMICAL STABILITY:
Stable
INC OMPATIBILITY WITH OTHER MATERIALS:
Incompatible with strong oxidants.
DECOMPOSITION:
Decomposes with heat.
Decomposition temperature: 300 C (572 F).
POLYMERIZATION:
Polymerization will not occur.
---------------------------------------------------------------------------
TOXICOLOGICAL INFORMATION
---------------------------------------------------------------------------
ANIMAL DATA:
Oral LD50: 18,800 mg/kg in rats
The compound is a slight eye irritant, but is neither a skin irritant nor a skin sensitizer in animals.
Toxic effects described in animals from exposure by ingestion include bladder hemorrhage and stomach
ulceration. Toxicity described for repeated doses include bladder calculi (stones), blood in the urine, and
decreased weight gain.
Toxicity described in animals administered the compound orally in the diet include bladder stones and
alterations of the urinary tract with tumors and squamous cell carcinomas, decreased growth rate and
altered relative organ weights.
Terephthalic acid is a carcinogen in rats when administered in large oral doses (>1,000 mg/kg/day). The
compound does not produce genetic damage in bacterial cell cultures. Animal testing indicates that this
compound does not have reproductive effects. Limited information from reproduction studies does not
indicate that terephthalic acid is a unique hazard to the conceptus.
DAK Americas LLC
Material Safety Data She et
---------------------------------------------------------------------------
DISPOSAL C ONSIDERATIONS
---------------------------------------------------------------------------
Page 7 of 9
WASTE DISPOSAL:
Treatment, storage, transportation and disposal must be in accordance with applicable Federal, State,
and local regulations. Recover non-usable free liquid and dispose of in an
approved and permitted incinerator. Recover contaminated liquid and dispose of in an approved and
permitted biological treatment system. Remove non-usable solid material and/or contaminated soil, for
disposal in an approved and permitted landfill.
---------------------------------------------------------------------------
TRANSP ORTATION INFORMATION
---------------------------------------------------------------------------
SHIPPING INFORMATION:
Shipping Containers
Tank Cars: 190,000 lbs. net
Tank Trucks: 50,000 lbs. net
TEREPHTHALIC ACID IS NOT REGULATED AS A HAZARDOUS MATERIAL BY DOT, IMO OR
IATA.
---------------------------------------------------------------------------
REGULATORY INFORMATION
---------------------------------------------------------------------------
U.S. FEDERAL REGULATIONS:
TSCA Inventory Status: Reported/Included.
TI TLE III HAZARD CLASSIFICATIONS SECTIONS 311, 312
Acute: Yes
Chronic: Yes
Fire: No
Reactivity: No
Pressure: No
LISTS:
SARA Extremely Hazardous Substance - No
CERCLA Hazardous Material - No
SARA Toxic Chemical - No
DAK Americas LLC
Material Safety Data She et
---------------------------------------------------------------------------
OTHER INFORMATION
---------------------------------------------------------------------------
NFPA, NPCA-HMIS:
Page 8 of 9
NFPA Rating:
Health: 0
Flammability: 1
Reactivity: 0
NPCA-HMIS Rating:
Health: 2
Flammability: 1
Reactivity: 0
---------------------------------------------------------------------
ADDITIONAL INFORMATION
---------------------------------------------------------------------
Dacron庐*** is a registered trademark of DuPont, licensed to DAK Americas LLC.
The data in this Material Safety Data Sheet relates only to the specific material designated herein and
does not relate to use in combination with any other material or in any process.
Responsible for MSDS: Cape Fear Site MSDS Coordinator
Address: 3500 Daniels Rd.
Leland, NC 28451
Telephone: 1-910-371-4000
Se e DAK Americas Caution Statem ent on next page.
End of MSDS
-------------------------------------------------------------------------
CAUTION
-------------------------------------------------------------------------
DAK Americas LLC Caution Bulletin No. 1
DO NOT USE DAK AMERICAS MATERIALS IN MEDICAL APPLICATIONS INVOLVING
PERMANENT, BRIEF, OR TEMPORARY IMPLANTATION IN THE HUMAN BODY OR
PERMANENT CONTACT WITH INTERNAL BODY FLUIDS OR TISSUES, UNLESS THE
MATERIAL HAS BEEN PROVIDED DIRECTLY FROM DAK AMERICAS UNDER A CONTRACT
WHICH EXPRESSLY ACKNOWLEDGES THE CONTEMPLATED USE.
DAK AMERICAS MAKES NO REPRESENTATION, PROMISE, EXPRESS WARRANTY OR
IMPLIED WARRANTY CONCERNING THE SUITABILITY OF THESE MATERIALS FOR USE IN
THE HUMAN BODY OR IN CONTACT WITH INTERNAL BODY FLUIDS OR TISSUES.
Page 9 of 9
THE CONTENT OF DAK AMERICAS MATERIAL IS NOT CERTIFIED FOR IMPLANTS. DAK
Americas materials are not designed or manufactured for use in implantation in the human body or in
contact with internal body fluids or tissues. DAK Americas has not performed clinical testing of these
materials for implantation. DAK Americas will not provide to customers making implantable devices
any notice concerning its materials, as specified under 21 C.F.R section 820.81, or any other
information necessary for medical device use of the materials under any other statue or FDA regulation.
DAK Americas has neither sought, nor received, approval from the FDA for the use of these materials
in implantation in the human body or in contact with internal body fluids or tissues.
ALL IMPLANTABLE MEDICAL DEVICES CARRY A RISK OF FAILURE AND ADVERSE
C ONSEQUENCES
The medical judgment of a physician, a medical device seller and the FDA should be relied upon for
identification of both harmful consequences and life-saving benefits from an implantation device
comprised of specific materials. These benefits and risks can be found in published medical cases
performing clinical medical studies of an implantable medical device. DAK Americas does not support
the use of its products in these applications and cannot weigh the benefits against the risk defined in
these articles. DAK Americas can not offer a medical judgment on the safety or efficacy of the use of
its materials in such devices.
DO NOT MAKE REFERENCE TO THE DAK AMERICAS NAME OR ANY DAK AMERICAS
TRADEMARK IN ASS O CIATION WITH AN IMPLANTABLE MEDICAL DEVICE.
Do not use a DAK Americas trademark or licensed trademark as the descriptive name of an implantable
medical device (e.g. do not call it the "Dacron庐" prosthesis", do not call it a "Delcron庐" prosthesis, or
do not call it a " Laser+庐 device" ).
End of Bulletin
|